VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Flulaval Quadrivalent
Vaccine Information
  • Vaccine Name: Flulaval Quadrivalent
  • Target Pathogen: Influenza virus
  • Target Disease: Influenza (flu)
  • Product Name: Influenza Virus Vaccine
  • Tradename: Flulaval Quadrivalent
  • Manufacturer: GlaxoSmithKline
  • Type: Inactivated or "killed" vaccine
  • Status: Licensed
  • Location Licensed: USA
  • Host Species for Licensed Use: Human
  • Preservative: Thimerosal
  • Allergen: Eggs
  • Immunization Route: Intramuscular injection (i.m.)
  • Storage: Store at 2º to 8ºC (36º to 46ºF), do not freeze.
  • Approved Age for Licensed Use: 6 months and older
  • Description: FLULAVAL QUADRIVALENT, Influenza Vaccine, for intramuscular injection, is a quadrivalent, split-virion, inactivated influenza virus vaccine prepared from virus propagated in the allantoic cavity of embryonated hens’ eggs. (FDA: Flulaval Quadrivalent)
Host Response
References
FDA: Flulaval Quadrivalent: FDA: Flulaval Quadrivalent vaccine information [https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM404086.pdf]